{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T17:52:14Z","timestamp":1770573134980,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejpb.2018.05.016","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T16:13:58Z","timestamp":1526487238000},"page":"10-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Progress in formulation development and sterilisation of freeze-dried oligodeoxynucleotide-loaded gelatine nanoparticles"],"prefix":"10.1016","volume":"129","author":[{"given":"Katharina J.","family":"Geh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madlen","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Winter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.05.016_b0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jconrel.2013.09.019","article-title":"Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research","volume":"172","author":"Elzoghby","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2018.05.016_b0010","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00134-012-2560-x","article-title":"Safety of gelatin for volume resuscitation\u2014a systematic review and meta-analysis","volume":"38","author":"Thomas-Rueddel","year":"2012","journal-title":"Intens. Care Med."},{"key":"10.1016\/j.ejpb.2018.05.016_b0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.ejpb.2018.05.016_b0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11095-007-9410-5","article-title":"Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides","volume":"25","author":"Zwiorek","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0025","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CJI.0b013e3181f5dfa7","article-title":"Delivery of immunostimulatory RNA oligonucleotides by gelatin nanoparticles triggers an efficient antitumoral response","volume":"33","author":"Bourquin","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.ejpb.2018.05.016_b0030","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.4049\/jimmunol.181.5.2990","article-title":"Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity","volume":"181","author":"Bourquin","year":"2008","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.ejpb.2018.05.016_b0035","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1007\/s11095-012-0686-8","article-title":"A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses","volume":"29","author":"Klier","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jvim.12524","article-title":"Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study","volume":"29","author":"Klier","year":"2015","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.ejpb.2018.05.016_b0045","doi-asserted-by":"crossref","DOI":"10.1111\/evj.12486_58","article-title":"Comparison of nanoparticulate CpG immunotherapy with and without allergens in rao-affected horses","volume":"47","author":"Klier","year":"2015","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.ejpb.2018.05.016_b0050","unstructured":"J. Klier, S. Geis, J. Steuer, K. Geh, S. Reese, S. Fuchs, R.S. Mueller, G. Winter, H. Gehlen, A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma-affected horses, an animal model, Immun., Inflammat. Dis. (2017) Epub ahead of print, 10.1002\/iid3.198."},{"key":"10.1016\/j.ejpb.2018.05.016_b0055","article-title":"In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs \u2013 a pilot study","volume":"24","author":"Rostaher-Pr\u00e9laud","year":"2013","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.ejpb.2018.05.016_b0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/vr.104230","article-title":"Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis","volume":"181","author":"Wagner","year":"2017","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ejpb.2018.05.016_b0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/02652048.2016.1228706","article-title":"Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production","volume":"33","author":"Geh","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2018.05.016_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vetimm.2011.07.009","article-title":"Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles","volume":"144","author":"Klier","year":"2011","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ejpb.2018.05.016_b0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejpb.2008.04.026","article-title":"Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles","volume":"70","author":"Zillies","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2013.04.014","article-title":"Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review","volume":"85","author":"Geidobler","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0085","unstructured":"T. Bosch, Aggressive Freeze-Drying, PhD Thesis, LMU Munich, 2014."},{"key":"10.1016\/j.ejpb.2018.05.016_b0090","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jps.22000","article-title":"Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying","volume":"99","author":"Schersch","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0095","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1002\/jps.23121","article-title":"Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, Part 2: Stability during storage at elevated temperatures","volume":"101","author":"Schersch","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2011.03.010","article-title":"The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals","volume":"78","author":"Kasper","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0105","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1002\/jps.22561","article-title":"Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate","volume":"100","author":"Konstantinidis","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0110","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1002\/jps.23704","article-title":"Can controlled ice nucleation improve freeze-drying of highly-concentrated protein formulations?","volume":"102","author":"Geidobler","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0115","unstructured":"R.B.R.S.B. Hunek, A practical method for resolving the nucleation problem in lyophilization, BioProcess Int., 2009."},{"key":"10.1016\/j.ejpb.2018.05.016_b0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jps.23419","article-title":"Investigations on polyplex stability during the freezing step of lyophilization using controlled ice nucleation\u2014the importance of residence time in the low-viscosity fluid state","volume":"102","author":"Kasper","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0125","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00726-007-0506-3","article-title":"Biotechnology applications of amino acids in protein purification and formulations","volume":"33","author":"Arakawa","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejpb.2018.05.016_b0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1081\/PDT-100101354","article-title":"Formulation of proteins in vacuum-dried glasses. II. Process and storage stability in sugar-free amino acid systems","volume":"4","author":"Mattern","year":"1999","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2018.05.016_b0135","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2014.01.077","article-title":"Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates","volume":"32","author":"Scherlie\u00df","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2018.05.016_b0140","unstructured":"European Medicines Agency, Guideline on sterilisation of the medicinal product, active substance, excipient and primary container, EMA\/CHMP\/CVMP\/QWP\/BWP\/850374\/2015, 2016."},{"key":"10.1016\/j.ejpb.2018.05.016_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.fsigen.2009.06.008","article-title":"UV irradiation and autoclave treatment for elimination of contaminating DNA from laboratory consumables","volume":"4","author":"Gefrides","year":"2010","journal-title":"Foren. Sci. Int. Genet."},{"key":"10.1016\/j.ejpb.2018.05.016_b0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.18433\/J3JP4B","article-title":"A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments","volume":"12","author":"Austin","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5731\/pdajpst.2014.00955","article-title":"Gamma sterilization of pharmaceuticals\u2014a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations","volume":"68","author":"Hasanain","year":"2014","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.ejpb.2018.05.016_b0160","first-page":"51","article-title":"Radiation sterilization of new drug delivery systems","volume":"6","author":"Abuhano\u011flu","year":"2014","journal-title":"Inter. Med. Appl. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2005.09.012","article-title":"Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: protective effects of ascorbate","volume":"40","author":"Zbikowska","year":"2006","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejpb.2018.05.016_b0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/biol.2002.0330","article-title":"Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations","volume":"30","author":"Grieb","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.ejpb.2018.05.016_b0175","unstructured":"S. Margraf, A. Breuer, M. Scholz, J. Altrichter, Stabilizing compositions for immobilized biomolecules, US 20120107829 A1 (2010)."},{"key":"10.1016\/j.ejpb.2018.05.016_b0180","first-page":"22","article-title":"Gelatin nanoparticles as a new and simple gene delivery system","volume":"7","author":"Zwiorek","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0185","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1002\/jps.23308","article-title":"A new approach to achieve controlled ice nucleation of supercooled solutions during the freezing step in freeze-drying","volume":"101","author":"Geidobler","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0190","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1012180707283","article-title":"Rational design of stable lyophilized protein formulations: some practical advice","volume":"14","author":"Carpenter","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0195","doi-asserted-by":"crossref","unstructured":"L. Chang, D. Shepherd, J. Sun, D. Ouellette, K.L. Grant, X. Tang, M.J. Pikal, Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and\/or immobilization in a glassy matrix?, J. Pharm. Sci. 94, 1427\u20131444, 10.1002\/jps.20364.","DOI":"10.1002\/jps.20364"},{"key":"10.1016\/j.ejpb.2018.05.016_b0200","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0006-3495(96)79407-9","article-title":"Is trehalose special for preserving dry biomaterials?","volume":"71","author":"Crowe","year":"1996","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejpb.2018.05.016_b0205","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/jps.10094","article-title":"Mannitol\u2013sucrose mixtures\u2014versatile formulations for protein lyophilization","volume":"91","author":"Johnson","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejpb.2006.01.015","article-title":"Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage","volume":"63","author":"Abdelwahed","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0215","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ejps.2012.03.005","article-title":"A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)3\u2013PLA nanopolymersomes","volume":"46","author":"Ayen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0220","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejpb.2014.06.008","article-title":"Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability","volume":"88","author":"Dadparvar","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejpb.2009.02.002","article-title":"Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage","volume":"72","author":"Holzer","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.016_b0230","unstructured":"J. Zillies, Gelatin Nanoparticles for Targeted Oligonucleotide Delivery to Kupffer Cells-Analytics, Formulation Development, Practical Application, PhD Thesis, LMU M\u00fcnchen, 2007."},{"key":"10.1016\/j.ejpb.2018.05.016_b0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/abio.1997.2003","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry as a rapid quality control method in oligonucleotide synthesis","volume":"246","author":"Ball","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2018.05.016_b0240","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1021\/ac000225s","article-title":"Analysis of the degradation of oligonucleotide strands during the freezing\/thawing processes using MALDI-MS","volume":"72","author":"Davis","year":"2000","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2018.05.016_b0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijms.2014.10.001","article-title":"New features of DNA damage by acid hydrolysis in MALDI-TOF mass spectrum","volume":"374","author":"Liu","year":"2014","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.ejpb.2018.05.016_b0250","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/js960257o","article-title":"How does residual water affect the solid-state degradation of drugs in the amorphous state?","volume":"85","author":"Shalaev","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0255","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1023\/A:1018941810744","article-title":"The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids","volume":"11","author":"Hancock","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0260","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1023\/A:1012144810067","article-title":"Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody","volume":"14","author":"Duddu","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0265","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jps.24655","article-title":"Addition of amino acids to further stabilize lyophilized sucrose-based protein formulations: I. Screening of 15 amino acids in two model proteins","volume":"105","author":"Forney-Stevens","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0270","unstructured":"S. Ausar, Forced degradation studies: an essential tool for the formulation development of vaccines, Vaccine: Dev. Ther. 2013 (2013) 11\u201333 10.2147\/VDT.S41998."},{"key":"10.1016\/j.ejpb.2018.05.016_b0275","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1023\/A:1012199816852","article-title":"Development of a freeze-dried albumin-free formulation of recombinant factor VIII SQ","volume":"14","author":"\u00d6sterberg","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2018.05.016_b0280","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(00)00251-0","article-title":"Stabilization of lipid\/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis","volume":"1468","author":"Allison","year":"2000","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Biomembr."},{"key":"10.1016\/j.ejpb.2018.05.016_b0285","first-page":"509","article-title":"Radiation modification of physical properties of inorganic solids","volume":"35","author":"Pr\u00e1\u0161il","year":"1990","journal-title":"Int. J. Radiat. Appl. Instrum. Part C. Radiat. Phys. Chem."},{"key":"10.1016\/j.ejpb.2018.05.016_b0290","unstructured":"STERIS, Radiation Processing for Glass Coloration\/Discoloration, cited 08. November."},{"key":"10.1016\/j.ejpb.2018.05.016_b0295","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/bi047528r","article-title":"Role of arginine in the stabilization of proteins against aggregation","volume":"44","author":"Baynes","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejpb.2018.05.016_b0300","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1002\/j.1460-2075.1995.tb00268.x","article-title":"Identification of two novel arginine binding DNAs","volume":"14","author":"Harada","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.ejpb.2018.05.016_b0305","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1126\/science.287.5454.820","article-title":"Adaptive recognition by nucleic acid aptamers","volume":"287","author":"Hermann","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2018.05.016_b0310","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00396-004-1211-3","article-title":"Nanometer-sized gelatin particles prepared by means of gamma-ray irradiation","volume":"283","author":"Furusawa","year":"2004","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.ejpb.2018.05.016_b0315","doi-asserted-by":"crossref","unstructured":"M.N. Uddin, K.I. Cotty, M.J. Dsouza, Stability Determination and Evaluation of Gamma-Irradiated Nuclear Factor-\u03baB Antisense Microsphere Drug Design Development & Therapy 1(2016) 00001, 10.15406\/mojddt.2016.01.00001.","DOI":"10.15406\/mojddt.2016.01.00001"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118301383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118301383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T03:40:35Z","timestamp":1571370035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118301383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":63,"alternative-id":["S0939641118301383"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in formulation development and sterilisation of freeze-dried oligodeoxynucleotide-loaded gelatine nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}